Triangle of Diabetes Care

HbA1c is an accepted measure of overall glucose control over the past three months and illustrates how a person with diabetes has been managing their treatment regime.

The FreeStyle Libre systems are proven to significantly lower HbA1c compared to SMBG. An independent study published in the New England Journal of Medicine shows that FreeStyle Libre 2 system reduces HbA1c by 0.5%.^1,**

• 156 people with T1D ≥16 years with HbA1c ≥7.5% paticipated in a randomised, controlled study¹
• FreeStyle Libre 2 users reduced their HbA1c by 0.5% more than SMBG at 6 months of use^{1,^}

Find out more about improving overall glucose levels, how greater diabetes control is associated with better long-term outcomes and the limitations of HbA1c in our Healthcare Professional Education module about the Triangle of Diabetes Care.

Even if your patient’s HbA1c is on target, they may have been experiencing daily swings between high and low glucose levels or significant day-to-day glucose variability.

Avoiding glucose excursions and minimising the size of these daily swings are important for improving your patient’s overall health and management of their diabetes.⁴ In fact, the DCCT study showed that changes in a patient’s mean daily glucose as well as pre- and post-prandial hyperglycaemia were a better predictor of cardiovascular disease than HbA1c.⁵

Find out more about limiting glucose variability in our Healthcare Professional Education modules about the Triangle of Diabetes Care and Targeting Glucose Variability.